Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for HSIC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -158.00M
March 31, 2026 152.00M
December 31, 2025 -208.00M
September 30, 2025 -125.00M
June 30, 2025 60.00M
March 31, 2025 162.00M
December 31, 2024 -204.00M
September 30, 2024 3.00M
June 30, 2024 3.00M
March 31, 2024 -57.00M
December 31, 2023 394.00M
September 30, 2023 254.00M
June 30, 2023 43.00M
March 31, 2023 29.00M
December 31, 2022 -189.00M
September 30, 2022 88.00M
June 30, 2022 -124.00M
March 31, 2022 -52.00M
December 31, 2021 -68.54M
September 30, 2021 -65.92M
June 30, 2021 -18.91M
March 31, 2021 -119.36M
December 31, 2020 -446.37M
September 30, 2020 -1.158M
June 30, 2020 -230.60M
Date Value
March 31, 2020 510.48M
December 31, 2019 -534.82M
September 30, 2019 -193.73M
June 30, 2019 -122.55M
March 31, 2019 585.98M
December 31, 2018 -283.86M
September 30, 2018 -96.17M
June 30, 2018 -225.30M
March 31, 2018 289.19M
December 31, 2017 -121.34M
September 30, 2017 24.36M
June 30, 2017 -68.12M
March 31, 2017 87.75M
December 31, 2016 -107.62M
September 30, 2016 -90.13M
June 30, 2016 -231.55M
March 31, 2016 201.80M
December 31, 2015 -147.83M
September 30, 2015 19.04M
June 30, 2015 -144.46M
March 31, 2015 35.98M
December 31, 2014 -166.14M
September 30, 2014 -7.011M
June 30, 2014 -121.61M
March 31, 2014 245.49M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Cencora, Inc. -1.768B
Accendra Health, Inc. -271.98M
Fuse Medical, Inc. --
Cardinal Health, Inc. -487.00M
McKesson Corp. 394.00M